510(k) K974811

ACCURUN(TM) 150 HSV IGG POSITIVE CONTROL by Boston Biomedica, Inc. — Product Code JJX

K974811 is an FDA 510(k) premarket notification submitted by Boston Biomedica, Inc. for the device "ACCURUN(TM) 150 HSV IGG POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on February 10, 1998. The device falls under product code JJX (Single (Specified) Analyte Controls (Assayed And Unassayed)), a Class I device regulated under 21 CFR 862.1660. Boston Biomedica, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
February 10, 1998
Date Received
December 23, 1997
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Single (Specified) Analyte Controls (Assayed And Unassayed)
Device Class
Class I
Regulation Number
862.1660
Review Panel
CH
Submission Type